{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T02:34:37Z","timestamp":1779244477848,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Cancer Institute, National Institutes of Health","award":["N01-CO-12400"],"award-info":[{"award-number":["N01-CO-12400"]}]},{"name":"NIAID\/NIH"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.clim.2012.01.014","type":"journal-article","created":{"date-parts":[[2012,2,7]],"date-time":"2012-02-07T11:10:35Z","timestamp":1328613035000},"page":"152-161","source":"Crossref","is-referenced-by-count":25,"title":["CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome"],"prefix":"10.1016","volume":"143","author":[{"given":"Xiying","family":"Fan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhaskar","family":"Upadhyaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nica","family":"Sant\u00edn-Dur\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Pittaluga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gulbu","family":"Uzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ester","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chi A.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron","family":"Bodansky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao B.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Edmonds","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Hornung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duane W.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Fayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Fleisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Calman","family":"Prussin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Jain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2012.01.014_bb0005","first-page":"101","article-title":"Immunodeficiency with hyper-IgM (HIM)","volume":"3","author":"Notarangelo","year":"1992","journal-title":"Immunodefic. Rev."},{"key":"10.1016\/j.clim.2012.01.014_bb0010","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/361539a0","article-title":"Defective expression of T-cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM","volume":"361","author":"Korthauer","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.01.014_bb0015","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","article-title":"The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome","volume":"72","author":"Aruffo","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.clim.2012.01.014_bb0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1600-065X.2009.00782.x","article-title":"Molecular mechanism and function of CD40\/CD40L engagement in the immune system","volume":"229","author":"Elgueta","year":"2009","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2012.01.014_bb0190","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/361541a0","article-title":"CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM","volume":"361","author":"DiSanto","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.01.014_bb0030","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1385\/IR:24:3:311","article-title":"CD40:CD40L interactions in X-linked and non-X-linked hyper-IgM syndromes","volume":"24","author":"Bhushan","year":"2001","journal-title":"Immunol. Res."},{"key":"10.1016\/j.clim.2012.01.014_bb0195","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.md.0000100046.06009.b0","article-title":"The X-linked hyper-IgM syndrome: clinical and immunologic features of 79 patients","volume":"82","author":"Winkelstein","year":"2003","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.clim.2012.01.014_bb0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.0105-2896.2005.00229.x","article-title":"Hyper immunoglobulin M syndrome due to CD40 deficiency: clinical, molecular, and immunological features","volume":"203","author":"Lougaris","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2012.01.014_bb0045","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000236923","article-title":"CD40 ligand\/CD40 deficiency","volume":"107","author":"Castigli","year":"1995","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2012.01.014_bb0050","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1084\/jem.180.4.1263","article-title":"Activation of human dendritic cells through CD40 cross-linking","volume":"180","author":"Caux","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.01.014_bb0055","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1084\/jem.184.2.747","article-title":"Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T\u2013T help via APC activation","volume":"184","author":"Cella","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.01.014_bb0060","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s10875-009-9315-7","article-title":"Clinical and laboratory findings in hyper-IgM syndrome with novel CD40L and AICDA mutations","volume":"29","author":"Aghamohammadi","year":"2009","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.clim.2012.01.014_bb0065","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0022-3476(97)70123-9","article-title":"Clinical spectrum of X-linked hyper-IgM syndrome","volume":"131","author":"Levy","year":"1997","journal-title":"J. Pediatr."},{"key":"10.1016\/j.clim.2012.01.014_bb0070","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4049\/jimmunol.158.2.977","article-title":"Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM","volume":"158","author":"Hayward","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2012.01.014_bb0075","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1038\/378617a0","article-title":"Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand","volume":"378","author":"Grewal","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.01.014_bb0080","first-page":"239","article-title":"The efficacy of immunoglobulin replacement therapy in the long-term follow-up of the B-cell deficiencies (XLA, HIM, CVID)","volume":"47","author":"Bayrakci","year":"2005","journal-title":"Turk. J. Pediatr."},{"key":"10.1016\/j.clim.2012.01.014_bb0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1385\/CRIAI:19:2:205","article-title":"X-linked hyper IgM syndrome","volume":"19","author":"Schneider","year":"2000","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.clim.2012.01.014_bb0090","doi-asserted-by":"crossref","first-page":"600","DOI":"10.4269\/ajtmh.2010.09-0590","article-title":"Human CD8(+) T cells clear Cryptosporidium parvum from infected intestinal epithelial cells","volume":"82","author":"Pantenburg","year":"2010","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.clim.2012.01.014_bb0095","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.273.5283.1862","article-title":"CD40 ligand-dependent T cell activation: requirement of B7-CD28 signaling through CD40","volume":"273","author":"Yang","year":"1996","journal-title":"Science"},{"key":"10.1016\/j.clim.2012.01.014_bb0100","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/31002","article-title":"T-cell help for cytotoxic T lymphocytes is mediated by CD40\u2013CD40L interactions","volume":"393","author":"Schoenberger","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.01.014_bb0105","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1038\/30989","article-title":"A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell","volume":"393","author":"Ridge","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.clim.2012.01.014_bb0110","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1126\/science.1198443","article-title":"CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans","volume":"331","author":"Beatty","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.clim.2012.01.014_bb0115","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00262-011-1014-6","article-title":"The CD40 agonist antibody CP-870,893 enhances dendritic cell and B-cell activity and promotes anti-tumor efficacy in SCID-hu mice","volume":"60","author":"Gladue","year":"2011","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.clim.2012.01.014_bb0120","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1479-5876-7-93","article-title":"Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation","volume":"7","author":"Carpenter","year":"2009","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clim.2012.01.014_bb0125","doi-asserted-by":"crossref","first-page":"983","DOI":"10.4161\/cbt.10.10.13251","article-title":"Immune modulation with weekly dosing of an agonist CD40 antibody in a phase I study of patients with advanced solid tumors","volume":"10","author":"Ruter","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.clim.2012.01.014_bb0205","doi-asserted-by":"crossref","first-page":"7.1.1","DOI":"10.1002\/0471142735.im0701s85","article-title":"Isolation of whole mononuclear cells from peripheral blood and cord blood","volume":"85","author":"Fuss","year":"2009","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.clim.2012.01.014_bb0210","first-page":"195","article-title":"Superantigens: interaction of staphylococcal enterotoxins with MHC class II molecules","volume":"101","author":"Rich","year":"1990","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.clim.2012.01.014_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/0471142735.im0624s78","article-title":"Detection of intracellular cytokines by flow cytometry","volume":"24","author":"Foster","year":"2007","journal-title":"Curr. Protoc. Immunol."},{"key":"10.1016\/j.clim.2012.01.014_bb0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/85277","article-title":"Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia","volume":"2","author":"Jain","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2012.01.014_bb0150","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1128\/AEM.65.4.1578-1583.1999","article-title":"Phylogenetic analysis of Cryptosporidium parasites based on the small-subunit rRNA gene locus","volume":"65","author":"Xiao","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.clim.2012.01.014_bb0155","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI5891","article-title":"Defects of T-cell effector function and post-thymic maturation in X-linked hyper-IgM syndrome","volume":"103","author":"Jain","year":"1999","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.clim.2012.01.014_bb0220","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1006\/smim.1994.1042","article-title":"The role of CD40L (gp39)\/CD40 in T\/B cell interaction and primary immunodeficiency","volume":"6","author":"Ochs","year":"1994","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2012.01.014_bb0165","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1084\/jem.184.2.741","article-title":"High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10","volume":"184","author":"Koch","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2012.01.014_bb0170","doi-asserted-by":"crossref","first-page":"3811","DOI":"10.1182\/blood-2011-04-351254","article-title":"Partial immune reconstitution of X-linked hyper IgM syndrome with recombinant CD40 ligand","volume":"118","author":"Jain","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.clim.2012.01.014_bb0175","doi-asserted-by":"crossref","first-page":"3280","DOI":"10.1200\/JCO.2001.19.13.3280","article-title":"Phase I study of recombinant human CD40 ligand in cancer patients","volume":"19","author":"Vonderheide","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2012.01.014_bb0180","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/3233","article-title":"Thymic lymphoproliferative disease after successful correction of CD40 ligand deficiency by gene transfer in mice","volume":"4","author":"Brown","year":"1998","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2012.01.014_bb0185","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.cgt.0234","article-title":"Lymphoid abnormalities in CD40 ligand transgenic mice suggest the need for tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome","volume":"7","author":"Sacco","year":"2000","journal-title":"Cancer Gene Ther."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661612000368?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661612000368?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T10:47:05Z","timestamp":1686739625000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661612000368"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1521661612000368"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2012.01.014","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}